Main container

Metformina come terapia di mantenimento in sarcomi ossei ad alto rischio di ricaduta

Title
Metformina come terapia di mantenimento in sarcomi ossei ad alto rischio di ricaduta
Code
Metformina-Bone
Type
Sperimentale
Start Year
2021
Status
In Corso

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Clinical Trial
A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors
Read more
Clinical Trial
Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors
Read more